Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

5 Dec 2023 07:00

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, December 05

5 December 2023

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2023 (the “Period”).

Chairman’s Statement

Following the announcement with Marechale’s full year results released in August 2023, the market continues to remain challenging, particularly in the hospitality sector. However, the Board remains positive about the outlook for its investments.

Marechale Capital continues to see interesting corporate finance and advisory projects where it can take founders shares and warrants as part of its advisory fees. On a positive note, Marechale has completed transactions during the period for the European telecommunications technology company, Fast2fibre, Chestnut Group, the leading East Anglian Inn Group, and for Brewhouse & Kitchen, the expanding gastro pub business. However, the market remains a difficult environment in which to raise capital. This has resulted in some advisory projects that launched in the summer not being completed by the end of the Period. Marechale continues to look for new funding partners alongside its traditional investor relationships.

During the six months ended 31 October 2023, the Company generated gross profits of £93,813 (2022: £72,020) and delivered an operating loss of £155,421 (2022: loss of £178,995), resulting in an overall loss before tax of £155,803 (2022: loss of £179,502).

The Company’s balance sheet shows a net asset value of £3,340,486 (2022: £3,456,430), representing 3.15p (2022: 3.62p) of value per share in issue. The Company remains positive about the investments that it holds in its client companies. As at 31 October 2023 the Company had £400,000 of cash reserves.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with Chris Kenning, following his strategic investment of 9.9% of the Company announced in June 2023. The plan is to digitise Marechale’s activities and continue to develop strategic partnerships with the objective of enhancing shareholder value.

Marechale also uses its balance sheet to co-invest in its client companies, along with warrants and founder equity. Furthermore, the Board is hopeful to be able to announce realisations on some of the Company’s investments in the next six months

Whist the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

For further information please contact:

Marechale CapitalMark Warde-Norbury / Patrick Booth-ClibbornTel: +44 (0)20 7628 5582
Cairn Financial Advisers LLPJo Turner / Sandy Jamieson Tel: +44 (0)20 7213 0880
Income Statement (unaudited)
6 months ended 31 October20232022
£
Revenue320,603168,001
Cost of sales(226,790)(95,981)
Gross profit 93,81372,020
Administrative expenses(249,235)(251,015)
Operating loss(155,421)(178,995)
Interest paid(382)(507)
(Loss/profit before tax(155,803)(179,502)
Taxation--
(Loss)/profit after tax(155,803)(179,502)
(Loss)/profit per share
(Pence)(Pence)
- Basic(0.15)(0.19)
- Diluted(0.14)(0.19)
Balance Sheet (unaudited)
As at31 October31 October
20232022
Current assets
Available for sale investments2,863,2273,116,441
Trading investments130,076146,589
Trade and other receivables37,21954,356
Cash and cash equivalents398,229246,808
3,428,7513,564,194
Current liabilities

Trade and other payables

PAYE

Bounce-back Loan

(51,278)

(9,487)

(10,000)

(59,627)

(10,638)

(10,000)

Total current liabilities(70,765)(80,265)
Net current assets3,357,9863,483,929
Bounce-back Loan – long-term(17,500)(27,500)
Net assets3,340,4863,456,429
Equity
Capital and reserves attributable to equity shareholders

Share capital

Share premium

847,530

481,290

763,023

328,413

Reserve for own shares(50,254)(50,254)
Retained profits/ (losses)1,944,8422,346,660
Reserve for share based payments117,07868,587
3,340,4863,456,429
Cash Flow Statement (unaudited)
6 months ended31 October31 October
20232022
££
Net cash from operating activities
Loss after tax (155,803)(179,502)

Provision for share based payments

Reverse interest paid

33,091

381

6,275

507

Operating cash flows before movements in working capital(122,331)(172,720)
Movement in working capital
Decrease/ (increase) in receivables38,714(10,580)
(Decrease)/ Increase in payables(30,795)12,895
Net movement in working capital7,9192,315
Operating cash out-flow(114,412)(170,405)
Investment activities
Expenditure on available for sale investments(572)-
Proceeds from sale of investments-8,750
Cash flow from investing activities(572)8,750

Financing

Share Capital

Bounce-back Loan repayments

Interest paid

Net financing

235,800

(5,000)

(381)

230,419

-

(5,000)

(507)

(5,507)

Net increase/ (decrease) in cash and cash equivalents115,435(167,162)
Cash and cash equivalents at start of the period282,794413,970
Cash and cash equivalents at end of the period398,229246,808
Increase/ (decrease) in cash and cash equivalents115,435(167,162)

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
8th Jun 20267:00 amPRNFCA Approves Stanford Capital Partners Change in Control
3rd Jun 20267:00 amPRNPosting of Circular and Notice of General Meeting
10th Apr 20261:00 pmPRNWeardale Lithium Receives £700k Grant
19th Jan 202612:15 pmPRNHalf-year Report
14th Oct 20254:00 pmPRNResult of AGM
14th Oct 20257:00 amPRNSubscription, Directors' Dealings, Related Party Transaction and Issue of Equity
16th Sep 20259:30 amPRNNotice of AGM
22nd Aug 20257:00 amPRNFinal Results
13th May 20257:00 amPRNIssue of Options to PDMR
19th Mar 20257:00 amPRNMarechale Advises on the Sale of Randalls
5th Feb 20251:30 pmPRNWeardale Lithium Planning Permission Application Update
29th Jan 202511:37 amPRNShare Price Movement
19th Dec 20244:30 pmPRNHalf-year Report
15th Oct 20242:30 pmPRNResult of AGM
20th Sep 20247:00 amPRNNotice of AGM
20th Aug 20247:00 amPRNFinal Results
6th Aug 20247:00 amPRNAppointment of Director
5th Dec 20237:00 amPRNHalf-year Report
22nd Nov 20231:00 pmPRNDirectorate Change
13th Oct 20233:51 pmPRNResult of AGM
19th Sep 20233:40 pmPRNNotice of AGM and Posting of Accounts
22nd Aug 20237:00 amPRNFinancial Statements for the Year Ended 30 April 2023
3rd Aug 202312:00 pmPRNHolding(s) in Company
28th Jun 20237:00 amPRNSubscription and Issue of Equity
2nd Mar 20227:00 amPRNPlacing, Subscription and Issue of Equity
1st Dec 20217:00 amPRNHalf-year Report
14th Oct 20213:28 pmRNSResult of AGM
11th Oct 20213:08 pmPRNHolding(s) in Company
8th Oct 20213:29 pmPRNHolding(s) in Company
5th Oct 20217:00 amPRNSubscription and Issue of Equity
22nd Sep 20212:57 pmPRNNotice of AGM
8th Sep 202111:54 amPRNHolding(s) in Company
7th Sep 20212:11 pmPRNDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSFinal Results
12th Mar 20219:32 amPRNHolding(s) in Company
5th Mar 20211:29 pmPRNHolding(s) in Company
5th Mar 20218:50 amPRNHolding(s) in Company
4th Mar 20213:24 pmPRNTrading Update
4th Mar 20219:19 amPRNHolding(s) in Company
23rd Feb 20215:00 pmPRNHolding(s) in Company
23rd Feb 20217:00 amPRNDirector/PDMR Shareholding
10th Feb 20212:27 pmPRNHolding(s) in Company
10th Feb 20217:00 amPRNHolding(s) in Company
4th Feb 20219:15 amPRNExercise of Options and Issue of Equity
3rd Feb 20217:00 amPRNStatement re Share Price Movement
2nd Feb 20216:20 pmPRNHolding(s) in Company
26th Jan 202111:47 amPRNPlacing, Subscription and Issue of Equity
11th Dec 202012:47 pmPRNGrant of Options to Directors
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.